By taking a majority stake in dynamic dietary supplements firm Braineffect, Germany's Schwabe can reach a new, younger target audience for its OTC herbal medicines.
A round-up of the latest consumer health industry appointments: GSCF elects chair; Kenvue hires Northern Europe head; Barentz names chief commercial officer.
Bayer Consumer Health hopes its new InflammAge saliva-based biomarker can help “revolutionize self-care and how people can manage their aging journey.”
A week after announcing 2024 full-year and fourth-quarter results, the firm says its corporate name will be Niagen Bioscience Inc. starting 19 March. It stated in its latest results that during 2024 it launched Niagen Plus line of pharmaceutical-grade Niagen.
Direct seller has deals to fully acquire and 51% ownership of Link BioSciences, which formulates personalized supplements. It also announced a deal to acquire Pruvit Ventures, ketone supplements direct seller.
TikTok dietary supplement sales in Thailand grew by an astonishing 635% in 2024, while sales via Vietnam's and Malaysia's traditional e-commerce platforms increased by a still impressive 73% and 83% respectively.
National Advertising Division finds Magni Group didn’t support claims made on MagniLife Gel packaging, in direct-mail advertisements and online and in social media “Rapid Pain Relief.”
Ashley Graham promotes OLLY; Robles BioCeutics adds financial and science chiefs; Graham Rigby leads AHPA; Vit-Best Nutrition appoints Jeffrey Stallings president; BodyHealth collaborates with NBA player Bam Adebayo; and Bucked Up adds Alex Eubank as brand ambassador.
UK-based consumer health giant reports organic sales growth of 5.0% in 2024 as gains for its power brands offset a softer cold & flu season, particularly in the US.
Australia's SFI Health looking to take Equazen omega-3 fatty acids supplement to new markets to capitalize on Europe's fast-growing brain health segment.
Funding, expert support available for Nature’s Way Innovation Challenge picks; Xymogen adds direct-to-consumer sales in brand update; and Nutrishop pitches franchise opportunities.
AI prowess “will not be a competitive advantage long-term. It's going to be table stakes. But there are people who are going to get there sooner and they will have an advantage for a while,” says C&D CEO Matthew Farrell. P&G’s investment in AI, meanwhile, produced its “Great Idea Generator proprietary platform.”
A journey began eight years ago continues for Doc Generici – now rebranded as DOC Pharma – as it continues to diversify its offerings beyond conventional generic prescription pharmaceuticals.
Analysts hold back on predicting new heights for B+L until full split from parent firm. It reported Q4 revenue up 9% to $1.28bn and full-year revenue up 16% to $4.79bn.
UK firm links up with ingredients giant Kemin to offer probiotics for cardiometabolic health.
Along with its 2024 full-year and fourth-quarter results – both down slightly – the Los Angeles-based firm on 19 February announced its board appointed Stephan Gratziani, president since January 2024, as CEO effective 1 May.
Venture capital fund backed by Germany's Schwabe has €100m to invest in consumer health startups operating in categories such as sleep and mental health.
Demand returns for Nestle's US dietary supplement brands following supply chain issues, helping the firm's Health Science division post a solid uplift in sales for 2024.
As Norway's Orkla Health searches for a new CEO, the business looks well-placed for future growth after a 15% uplift in sales in 2024.
US consumer survey commissioned by NOW Health suggests energy could dominate wellness priorities in 2025 while CRN’s most recent survey showed use of specific supplements such as magnesium, prebiotics and ashwagandha increased compared to previous years. Overall interest in vitamin, mineral and supplement products is higher in several other countries, according to Statista.